Sentence examples for most trials at from inspiring English sources

Furthermore, adverse events in the cornea occurred in most trials at low frequencies; at the most in 3 4% of patients in Ganfort® and Xalacom® trials [ 18, 19, 31, 32].

Most trials aiming at reducing mortality in CKF failed to meet the primary end point [ 7].

Most trials aimed at preventing weight gain typically enrolled weight concerned women, but did not provide clear evidence that this group were at risk of greater weight gain.

Most trials were at high or unclear risk of detection or reporting bias due to no description of blinding of outcome assessors.

Most trials showed at least some evidence of transgressive segregation, with RILs flowering both earlier than green millet and later than foxtail millet, although in only three trials was there a large amount of transgressive segregation.

However, most trials were at high risk of bias: Only 19 out of 30 trials used appropriate methods of randomization, only 16 trials reported allocation concealment, only four trials reported blinding of outcomes and in eight trials participant withdrawals were not reported.

The variability of dual antiplatelet therapy, however, could be less important in the context of the present meta-analysis given that BMS were excluded and most trials used at least six months of dual antiplatelet therapy (a summary of current guideline recommendations 121 is in the appendix).

Although an explanation for the emergence of use of a modified intention to treat approach in the medical literature remains unclear, this phenomenon may reflect the difficulty that investigators face when managing missing data or deviations from protocol (present in most trials) and at the same time avoid using the intention to treat terminology.

This is because most trials only look at changing one component of a complex treatment at a time.

The primary outcome for most trials was measured at 6 months, with an extension phase of up to 12 months.

The larger number of patients included in cohort C is related to the fact that most trials dose expanded at the MTD level.